Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Neoplasms of the CNS

  Free Subscription


4 AJNR Am J Neuroradiol
1 BMC Cancer
1 Br J Cancer
1 Brain
1 Childs Nerv Syst
1 Clin Cancer Res
7 J Neurooncol
1 J Neuropathol Exp Neurol
4 J Neurosurg
12 Neuro Oncol
1 Neuroradiology
1 Radiol Artif Intell

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJNR Am J Neuroradiol

  1. SUN W, Xu D, Yang Y, Wen L, et al
    Improved Detection of Target Metabolites in Brain Tumors with Intermediate TE, High SNR, and High Bandwidth Spin-Echo Sequence at 5T.
    AJNR Am J Neuroradiol. 2024 Mar 7. doi: 10.3174/ajnr.A8150.
    PubMed         Abstract available

  2. RAMAKRISHNAN D, Bruningk SC, von Reppert M, Memon F, et al
    Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of BRAF V600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial.
    AJNR Am J Neuroradiol. 2024 Mar 7. doi: 10.3174/ajnr.A8189.
    PubMed         Abstract available

  3. YAMIN G, Tranvinh E, Lanzman BA, Tong E, et al
    Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
    AJNR Am J Neuroradiol. 2024 Mar 7. doi: 10.3174/ajnr.A8190.
    PubMed         Abstract available

  4. AGARWAL A, Edgar MA, Desai A, Gupta V, et al
    Molecular GBM versus Histopathological GBM: Radiology-Pathology-Genetic Correlation and the New WHO 2021 Definition of Glioblastoma.
    AJNR Am J Neuroradiol. 2024 Mar 4:ajnr.A8225. doi: 10.3174/ajnr.A8225.
    PubMed         Abstract available

    BMC Cancer

  5. MENG J, Qian W, Yang Z, Gong L, et al
    p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
    BMC Cancer. 2024;24:317.
    PubMed         Abstract available

    Br J Cancer

  6. JOO JE, Chu YL, Georgeson P, Walker R, et al
    Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer.
    Br J Cancer. 2024 Jan 10. doi: 10.1038/s41416-023-02554.
    PubMed         Abstract available


  7. COLETTA L, Avesani P, Zigiotto L, Venturini M, et al
    Integrating direct electrical brain stimulation with the human connectome.
    Brain. 2024;147:1100-1111.
    PubMed         Abstract available

    Childs Nerv Syst

  8. ADELHOEFER SJ, Feghali J, Rajan S, Eberhart CG, et al
    An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis.
    Childs Nerv Syst. 2024 Mar 7. doi: 10.1007/s00381-024-06350.
    PubMed         Abstract available

    Clin Cancer Res

  9. SCHRECK KC, Strowd RE, Nabors LB, Ellingson BM, et al
    Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma.
    Clin Cancer Res. 2024 Mar 6. doi: 10.1158/1078-0432.CCR-23-3241.
    PubMed         Abstract available

    J Neurooncol

  10. LIM MJR, Zhang Z, Zheng Y, Khoo IWL, et al
    Effect of sarcopenia and frailty on outcomes among patients with brain metastases.
    J Neurooncol. 2024 Mar 2. doi: 10.1007/s11060-023-04542.
    PubMed         Abstract available

  11. CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
    Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
    J Neurooncol. 2024 Mar 4. doi: 10.1007/s11060-024-04627.
    PubMed         Abstract available

  12. YOKOGAMI K, Watanabe T, Yamashita S, Mizuguchi A, et al
    Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma.
    J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04625.
    PubMed         Abstract available

  13. SINGH E, Gurses ME, Costello MC, Berke C, et al
    Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04619.

  14. GRAILLON T, Salgues B, Horowitz T, Padovani L, et al
    Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
    J Neurooncol. 2024 Mar 7. doi: 10.1007/s11060-024-04622.
    PubMed         Abstract available

  15. DI NUNNO V, Lombardi G, Simonelli M, Minniti G, et al
    The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
    J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04589.
    PubMed         Abstract available

  16. PALAVANI LB, Silva GM, Borges PGLB, Ferreira MY, et al
    Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis.
    J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04621.
    PubMed         Abstract available

    J Neuropathol Exp Neurol

  17. DONEV K, Sundararajan V, Johnson D, Balan J, et al
    Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
    J Neuropathol Exp Neurol. 2024 Mar 6:nlae018. doi: 10.1093.
    PubMed         Abstract available

    J Neurosurg

  18. CHIANG VL, Pugazenthi S, Leidig WA, Rodriguez A, et al
    Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series.
    J Neurosurg. 2024 Mar 8:1-11. doi: 10.3171/2023.12.JNS231542.
    PubMed         Abstract available

  19. OHTSUKA Y, Suehiro S, Inoue A, Ohnishi T, et al
    Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery.
    J Neurosurg. 2024 Mar 8:1-11. doi: 10.3171/2023.12.JNS231506.
    PubMed         Abstract available

  20. COTE DJ, Kruchko C, Barnholtz-Sloan JS, Zada G, et al
    Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
    J Neurosurg. 2023;140:724-734.
    PubMed         Abstract available

  21. OSORIO RC, Haddad AF, Hart DM, Goldrich N, et al
    Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
    J Neurosurg. 2023;140:712-723.
    PubMed         Abstract available

    Neuro Oncol

  22. KOTECHA R, La Rosa A, Mehta MP
    How proton therapy fits into the management of adult intracranial tumors.
    Neuro Oncol. 2024;26.
    PubMed         Abstract available

  23. PALMER JD, Perlow HK, Lehrer EJ, Wardak Z, et al
    Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma.
    Neuro Oncol. 2024;26.
    PubMed         Abstract available

  24. TSENG CL, Zeng KL, Mellon EA, Soltys SG, et al
    Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon.
    Neuro Oncol. 2024;26.
    PubMed         Abstract available

  25. BREEN WG, Aryal MP, Cao Y, Kim MM, et al
    Integrating multi-modal imaging in radiation treatments for glioblastoma.
    Neuro Oncol. 2024;26.
    PubMed         Abstract available

  26. MAYO ZS, Billena C, Suh JH, Lo SS, et al
    The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
    Neuro Oncol. 2024;26.
    PubMed         Abstract available

  27. SAHGAL A, Chang S
    Pushing the boundaries of radiation technology for the management of central nervous system tumors.
    Neuro Oncol. 2024;26.

  28. COY S, Lee JS, Chan SJ, Woo T, et al
    Systematic characterization of antibody-drug conjugate targets in central nervous system tumors.
    Neuro Oncol. 2024;26:458-472.
    PubMed         Abstract available

  29. SHIXUE Y, Qi Z, Dongyuan S, Xiaoteng C, et al
    HIF1alpha/ATF3 partake PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma.
    Neuro Oncol. 2024 Mar 5:noae040. doi: 10.1093.
    PubMed         Abstract available

  30. LEE MD, Jain R
    Harnessing Generative AI for Glioma Diagnosis: A Step Forward in Neuro-Oncologic Imaging.
    Neuro Oncol. 2024 Mar 5:noae043. doi: 10.1093.

  31. ARRILLAGA-ROMANY I, Lassman A, McGovern SL, Mueller S, et al
    ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
    Neuro Oncol. 2024 Mar 6:noae031. doi: 10.1093.
    PubMed         Abstract available

  32. TABOURET E, Furtner J, Graillon T, Silvani A, et al
    3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
    Neuro Oncol. 2024 Mar 7:noae037. doi: 10.1093.
    PubMed         Abstract available

  33. HUANG H, Shah H, Hao J, Lin J, et al
    LncRNA LUCAT1 Promotes Glioblastoma Progression by Enhancing HIF1alpha Activity.
    Neuro Oncol. 2024 Mar 8:noae036. doi: 10.1093.
    PubMed         Abstract available


  34. AHMED G, Abou-Foul M, Sage W, McConachie N, et al
    Endovascular stenting for cerebral venous sinus stenosis secondary to meningioma invasion.
    Neuroradiology. 2024 Mar 2. doi: 10.1007/s00234-024-03321.
    PubMed         Abstract available

    Radiol Artif Intell

  35. TAK D, Ye Z, Zapaischykova A, Zha Y, et al
    Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.
    Radiol Artif Intell. 2024 Mar 6:e230333. doi: 10.1148/ryai.230333.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.